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Abstract. Chronic Kidney Disease (CKD) is an immense health issue. The prevalence is 
increasing each year worldwide, including Indonesia. Consistent with this trend, the 
prevalence of hemodialysis (HD) as a therapy is also increasing. CKD as well as HD often 
result in some complications, one being gastrointestinal disorders. Many factors are  
correlated  with the incidence of gastrointestinal disorders in CKD patients undergoing HD. 
This is an observational analytical research with cross-sectional study at RS Khusus Ginjal 
Rasyida Medan. The datas used in the research are primary datas, obtained from 
Gastrointestinal Symptoms Rating Scale (GSRS) questionnaire to assess severity of 
gastrointestnal disorders in HD patients, and secondary datas, obtained from medical 
records of age, smoking history, use of aspirin, HD duration, BUN, and Kt/V (as a 
parameter of HD adequacy). Then the datas are analyzed univariately, bivariately, and 
mutivariately using biner logistic regression model. All patients (100%) suffer from 
gastrointestinal disorders, with the most common being mild ones (67,1%). Final 
multivariate analysis shows that the duration of HD, BUN level, and Kt/V are significantly  
correlated  with worsening gastrointestinal disorders (OR:14,157 ,95%CI 2,851 ± 71,183, 
p=0,001; OR: 8,352, 95%CI 0,914 ± 76,344, p= 0,060; OR:8,219 ,95%CI 0,893 ± 75,674, 
p= 0,063). 
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1 Introduction 
Each year, the prevalence of chronic kidney disease (CKD) is increasing1. According to 
Riset Kesehatan Dasar (Riskesdas) 2013, the prevalence of the citizens in Indonesia 
who suffered from CKD was 0.2%. Following the trend of increased prevalence of 
CKD, the number of people who go through hemodialysis (HD) was also increased. 
According to Riskesdas 2018, it was recorded that 19,3% of the population going 
through hemodialysis therapy.2 CKD and HD can cause various complications, and 
gastrointestinal disorder is one of them. The complications in the gastrointestinal tract 
are fairly often found in kidney failure patients. 3 These gastrointestinal problems are 
constipation, abdominal pain, diarrhea, gastroesophageal reflux disease, indigestion, and 
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eating disfunction.4 The gastrointestinal disoders on CKD patients who undergo HD are 
caused by various factors, whether by uremia or the dialysis process, such as being 
elderly, use of aspirin, long-term dialysis, smoking, high blood urea nitrogen (BUN) 
ratio, and adequacy of HD (Kt/V). 5-9 Therefore, the authors are interested in conducting 
a study of the factors affecting gastrointestinal disorders in patients undergoing regular 
HD. 
2. Methodology 
This is an analytical observational research with a cross-sectional study design. This research 
was held in Rumah Sakit Khusus Ginjal Rasyida, Medan. Inclusion criteria in this research are 
patients over the age of 18 and agreed to be interviewed with the following exclusion criteria, 
patients who do not want to fill the questionnaire completely. Based on the calculation using the 
Lemeshow formula, there are 70 people who participated in this research. Datas were obtained 
from interview using Gastrointestinal Symptoms Rating Scale (GSRS) questionnaire that has 
been translated to Indonesian and validated with 0,75 reliability score. This questionnaire is 
used to assess severity of gastrointestinal disorders and consists of 15 questions to which 
answers are never(0), sometimes(1), often(2), and always(3). The overall score is catagorized 
into mild (0-15) and severe (16-45).10 In addition, the datas were also obtained from medical 
records to record the BUN ratio, Kt/v, age, use of aspirin, smoking history, and duration of HD. 
The statistical analysis is held using 24th SPSS version. Datas will be tested using Chi-Square, 
if the data are not qualified to use Chi-Square, Fisher Exact Test is used instead. Variables with 
p value<0.25 are included in multivariates test, it is considered significant if p<0.05.  
3. Result 
In this research, it is shown in table 1 that regular HD patients who has gastrointestinal 
disorders mostly are of elderly age, 40-60 years old (51,4%) The average duration of 
HD is (33,71 ± 35,293) months. According to smoking history, many of the HD patients 
do not smoke (72,9%). The prevalence of HD patients who use aspirin are (21,4%). The 
average BUN ratio in HD patients is (62,4157 ± 4,66997). HD patients who got 
adequate hemodialysis are 14,7% 
 
The prevalence of regular HD patients who had gastrointestinal disorders based on 
Gastrointestinal Symptoms Rating Scale (GSRS) is (100%). According to GSRS, 
(67,1%) had mild gastrointestinal disorders and (32,9%) had severe gastrointestinal 
disorders. 
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Based on GSRS, there are 5 identifiable symptoms; abdominal pain (stomach pain, 
abdominal discomfort, nausea), reflux (reflux and heartburn), indigestion (rumbling, 
bloating, burping, passing gas or flatus), diarrhea (diarrhea, loose stools, urgent need for 
bowel movement), and constipation (constipation, hard stools, sensation of not 
completely emptying the bowel).4 According to the questionnaire, 29,1% had abdominal 




In this research, it is obtained that the most prevalent proportion undergoing HD at 
Rumah Sakit Khusus Ginjal Rasyida Medan is the elderly group (40-60 years old) with 
a percentage of (51,4%), this result is consistent with data obtained from Indonesia 
Renal Registry where, the most prevalent group to undergo HD was the 45-64-year-old 
group with a percentage of (59,13%).11 According to Hydarinia-Naieni et al, the most  
common group going through HD was patients of age 50 and above with percentage of 
(77,5%).8 Whereas in a research by Dong et al, it was obtained that the average age of 
patients undergoing HD was (58.67 ± 14.39), which is older compared to the average 
age in this research (47,66 ± 13,069). 4 
 
Average duration of HD that patients go through is (33,71 ± 35,293) months, which is 
shorter compared to that of Shabka et al, (2,98 ± 3,42) years or (35,76 ± 41,04) 
months.12 Patients with smoking history (27,1%) and using aspirin (smoking history and 
do not use aspirin 21,4%) are fewer than patients who do not. These findings are 
consistent with Hydarinia-Naieni et al in which the patients who have smoking history 
(8,75%) and use of aspirin (40%) are also fewer. 8 
 
The patients’ average BUN level is (62,4157 ± 4,66997) mg/dL. Whereas in Kim et al, 
it was obtained that the average BUN level was (52,20 ± 30,21) mg/dL.13 In this 
research, the average BUN level in patients with mild gastrointestinal is (62,354 ± 
5,336) mg/dL while those with severe gastrointestinal disorders show (62,543 ± 2,973) 
mg/dL, these datas are slightly higher compared to those of Carrera-Jiménez et al, in 
which the average BUN level for mild gastrointestinal disorders was (60 ± 15) mg/dL 
and for severe gastrointestinal disorders was (61,6 ± 26) mg/dL.5 
 
All patients in RSKG Rasyida Medan have Kt/V level more than 1,2, this finding is in 
parallel with the data obtained from Indonesia Renal Registry, where 74% patients 
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undergoing HD in Indonesia have already achieved Kt/V level target of more than 1,2. 
The adequate datas obtained in this research are only (14,3%) while the inadequate ones 
are (85,7%). The reason is because Kt/V is said to be adequate if the level is more than 
1,2 for patients undergoing HD three times a week and more than 1,8 for patients 
undergoing HD two times a week.11 Inadequate HD may cause non optimal therapy and 
will still cause sytemic problems that have been caused previously by CKD, and one of 
them is gastrointestinal disorders. Inadequate HD can still cause high urea level. Urea 
plays an important role in increased gastrin production that can cause irritation of 
mucosa, which then will lead to many gastrointestinal disorders.8 
 
Based on GSRS (Gastrontestinal Symptoms Rating Scale) used in this research, all 
patients have at least one gastrointestinal disorder. This data is consistent with Daniel et 
al in which 90% of the CKD patients going through HD had gastointestinal 
symptoms.14 In this research, it is obtained that indigestion is the most common 
symptom (71,8%) followed by constipation (45,7%), and the least common symptom is 
reflux (28,6%). But according to Zuvela et al,  the most common ones were dyspepsia, 
abdominal pain, and constipation.15 
 
Table 1 Baseline Characteristics of Regular Hemodialysis Patients at RS Khusus Ginjal Rasyida Medan 
Variable Mean ± SD, n (%) 
Age (years old) 
     Young Adult(18-40) 
     Adult(40-60) 
     Elderly(>60) 
Age (years old) 





      Adult (18-60) 57 (81,4) 
      Elderly (>60) 13(18,6) 
Aspirin  
      Yes 15(21,4) 
      No 55(78,6) 
Duration of Hemodialysis 33,71  ± 35,293 
      Short-term Hemodialisis (≤12 months) 22(31,4) 
      Long-term Hemodialysis (>12 months) 48(68,6) 
Blood Urea Nitrogen (BUN) 62,4157 ± 4,66997 
      High Risk (>56 mg/dl) 59(84,3) 
      Low Risk (<56 mg/dl) 11(15,7) 
Smoking History  
      Yes 19(27,1) 
      No 51(72,9) 
Kt/V ( 2 times a week) 
      Adequate 
      Inadequate 
Kt/V (3 times a week) 
      Adequate 
      Inadequate 
Kt/V 
1,4916 ± 0,07095 
1(1,6) 
60(98,4) 
1,5044 ± 0,03283 
9(100) 
0(0) 
1,4933  ± 0,06724 
      Adequate 10(14,3) 
     Inadequate 60(85,7) 
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Mean ± SD, n 
(%) 
p OR(95%CI) 
Age (tahun)  47,217 ±11,786 47,872 ± 13,771 
 
0,859 0,889 
      Adult (18-60) 57 19(33,3) 38(66,7)  (0,242 ± 
3,262) 
      Elderly (>60) 13 4(30,8) 9(69,2) 
 
  
Aspirin    
 
0,057 3,048 
      Yes 15 8(53,3) 7(46,7)  (0,941 ± 
9,871) 

















48 21(43,8) 27(56,3) 
 
  
Blood Urea Nitrogen 
(BUN) 
 62,543 ±2,973 62,354 ± 5,336 
 
0,063 5,946 
      High (>56 mg/dl) 59 22(37,3) 37(62,7)  (0,712 ± 
49,649) 




Smoking History    
 
0,315 1,745 
      Yes 19 8(42,1) 11(57,9)  (0,586 ± 
5,201) 
       No 51 15(29,4) 36(70,6) 
 
  
Kt/V  1,490 ±0,074 1,495 ±0,065 
 
0,092 5,211 
      Adequate 10 1(10,0) 9(90,0)  (0,618 ± 
43,919) 
     Inadequate 60 22(36,7) 38(63,3)   
aSignificant(p-value 
<0.05)  
     
 
Based on this research, the duration of hemodialysis is related significantly (p = 0,004) 
to the occurrence of worsening gastrointestinal disorders. This is consistent with the 
findings of Santoso et al which found that severe decreased appetite happened mostly in 
patients going through HD for more than a year, compared to those with duration of less 
than a year with the (p=<0,001), the decreased appetite is caused by gastrointestinal 
disorder. 16  This happened because long-term hemodialysis induce decrease in appetite. 
Gastrointestinal Problem rate(GSRS)  
      Mild(1-15) 47(67,1) 
      Severe(16-45) 23(32,9) 
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Long-term hemodialysis cause gastric problem that eventually will increase gastric acid 
and render patients to lose appetite and body weight significantly.17 
 
In this research, patients who use aspirin tend to have severe gastrointestinal disorders 
compared to ones who do not, with prevalence of (53,3% VS 27,3%). The reason 
behind this is aspirin can damage the mucosa of gastrointestinal wall. Ulcer formation 
by aspirin is caused by topical injury and systemic effect of prostaglandin mucosa layer 
depletion by COX inhibitor. Prostaglandin plays an important role in protecting the 
integrity of gastric mucosa by increasing local blood flow, synthesis and secretion of 
mucus and bicarbonate. Without the normal production of prostaglandin, gastric 
environment will be susceptible to exogenous (i.e. smoking) or endogenous factors (H. 
pylori, acid, pepsin, bile acid) and as the result, is more susceptible to developing gastric 
ulcer and bleeding as complications. Acid environment cause aspirin to stay unionized 
and accumulate in gastric mucosa cell, which change cell permeability and promp 
ulceration.18,19,20 However, statistically the use of aspirin does not have significant 
correlation with gastrointestinal problem (p=0,057). This finding is consistent with 
Hydarinia-Naieni et al (p=0,360).8 
 
In this research, patients who have smoking history tend to have severe gastrointestinal 
disorders compared to the ones who do not have smoking history, with prevalence of 
(42,1% VS 29,4%). This is because cigarette smoke and its active substances can cause 
mucosal cell death, inhibition of cell renewal, decrease in blood flow to gastrointestinal 
mucosa, and disturbance of mucosal immunity system.21 However, statistically in this 
research there is no significant correlation between smoking history and gastrointestinal 
problem (p=0,315). This is consistent with the findings in Fidekiewicz which stated that 
smoking did not have significant correlation with irritable bowel syndrome, which was 
a gastrointestinal disorder (p=0,144).22 
 
In this research, patients who have BUN  level  >56 mg/dL tend to have severe 
gastrointestinal disorder compared to the ones with BUN  level  less than 56 mg/dL, 
with the prevalence of (37,3% VS 9,1%). The reason behind is the high urea  level  in 
blood could cause uremic syndrome in advanced chronic kidney disease patients, which 
can lead to various systemic organ disorders, and gastrointestinal disorder is one of 
them. Urea can increase the diffusion of ion hydrogen back through mucosa wall and 
increase gastrin level due to decreased gastrin clearance through kidney. The increase in 
gastrin synthesis eventually acts as an important stimulus to acid secretion,one of 
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several factors related to gastric mucosa injury in kidney failure patients. Gastrin 
decreases pyloric sphincter tone, a high level of gastrin can cause biliary reflux, which 
will worsen mucosa injury. Even though statistically there is no significant correlation 
between BUN and degree of gastrointestinal problem (p=0,063), this is consistent with 
the findings in Hydarinia-Naieni et al (p=0,514). 3,8.23 
 
Patients with inadequate hemodialysis tend to have severe gastrointestinal disorder 
compared to patients with adequate hemodialysis (36,7% VS 10%). This is because the 
poor adequacy of hemodialysis may cause a non optimal therapy and will still cause 
sytemic problems that have been promoted previously by CKD, and one of them is 
gastrointestinal disorders. Inadequate hemodialysis can also causes urea to remain high. 
Urea plays a great role in increasing gastrin, which cause mucosa injury, eventually 
resulting in various digestive symptoms. However statistically, in this findings there is 
no significant correlation between Kt/V and degree of gastrointestinal problems 
(p=0,092). This is consistent with Gök et al with (p=0,18). 3,8,24 
 
In this research, statistically there is no significant correlation between age and 
gastrointestinal disorders (p=0,889). This finding is consistent with Hydarinia-Naieni et 
al (p=0.549), this can happen when the elder group patients, in answering the 
questionnaire, are affected by chronic symptoms they have had for a long time, which 
made them feel used to it, that the patients feel it is difficult to differentiate the degree 
of the symptoms. In other study, it is also stated that elder group patients are more 
conservative to pain and reluctant to tell others when the pain take place. 5,8,25 
 
According to the final result of multivariate analysis, hemodialysis duration is a 
dominant risk factor that cause worsening of gastrointestinal symptoms in regular 
hemodialysis patients with (p= 0,001). Patients that have been through hemodialysis for 
a long time (more than 1 year), are 14 times more likely to have severe gastrointestinal 
disorders. Followed by BUN (Blood Urea Nitrogen) and adequacy with (p= 0,063, OR= 
8,219 and p=0,060, OR= 8,352). 
 
Table 3 Final model of biner logistic regression 
Variabel OR 95% CI p value 






0,893 – 75,674 
0,060 
0,063 
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5. CONCLUSION  
1. The prevalence of hemodialysis patients having gastrointestinal disorders is 
100% with the most common being mild gastrointestinal disorders. (67,1%). 
2. There is significant correlation between hemodialysis duration and worsening of 
hemodialysis duration (p=0,004). 
3. Based on multivariate analysis, worsening gastrointestinal symptoms is affected 
by duration of hemodialysis as the dominant factor, followed by BUN level and 
adequate hemodialysis Kt/V, where long-term hemodialysis (≥12 months), high 
BUN level (≥ 56 mg/dL), adequate hemodialysis (≥1,2 for three times a week 
and ≥1,8 for twice a week) patients are 14,157; 8,352; and 8,219 times more at 
risk respectively in worsening of gastrointestinal disorders compared to patients 
with short-term hemodyalisis (<12 months), low BUN level (<56 mg/dL), and 
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